CHOLESTATIC PRURITUS - PATHOPHYSIOLOGY AND THERAPY WITH SPECIAL CONCERN ON ITS TREATMENT WITH 5-HYDROXYTRYPTAMINE SUBTYPE-3 RECEPTOR ANTAGONISTS

被引：0
|
作者：
SCHWORER, H
RAMADORI, G
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 1995年 / 33卷 / 05期
关键词：
CHOLESTIS; LIVER; PRURITUS; ITCH; NOCICEPTION; 5-HYDROXYTRYPTAMINE; SEROTONIN; 5-HT3 RECEPTOR ANTAGONIST; ONDANSETRON; TROPISETRON;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Our current knowledge about the pathophysiology of pruritus (itch) is summarized. Special concern is given to the hypotheses to explain itch due to cholestatic liver diseases (bile acids, generation of hepatic and intestinal pruritogens, endogenous opioids). Drugs used for the treatment of cholestatic itch are discussed in detail. On the basis of successful treatment of cholestatic itch with 5-hydroxytryptamine (serotonin) subtype-3 receptor antagonists the role of serotonin in nociception is discussed.
引用
收藏
页码：265 / 274
页数：10
相关论文
共 50 条
  • [1] Cholestasis of pregnancy, pruritus and 5-hydroxytryptamine 3 receptor antagonists
    Schumann, R
    Hudcova, J
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (09) : 861 - 862
  • [2] 5-HYDROXYTRYPTAMINE AND 5-HYDROXYTRYPTAMINE-3 RECEPTOR ANTAGONISTS
    FARTHING, MJG
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1991, 26 : 92 - 100
  • [3] RELIEF OF CHOLESTATIC PRURITUS BY A NOVEL CLASS OF DRUGS - 5-HYDROXYTRYPTAMINE TYPE-3 (5-HT3) RECEPTOR ANTAGONISTS - EFFECTIVENESS OF ONDANSETRON
    SCHWORER, H
    HARTMANN, H
    RAMADORI, G
    PAIN, 1995, 61 (01) : 33 - 37
  • [4] Effect of different 5-hydroxytryptamine receptor subtype antagonists on the micturition reflex in rats
    Testa, R
    Guarneri, L
    Angelico, P
    Velasco, C
    Poggesi, E
    Cilia, A
    Leonardi, A
    BJU INTERNATIONAL, 2001, 87 (03) : 256 - 264
  • [5] Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists
    Kovac, Anthony L.
    JOURNAL OF CLINICAL ANESTHESIA, 2006, 18 (04) : 304 - 318
  • [6] Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure
    Chen, Yuting
    Sun, Jingkang
    Fan, Xiude
    Wang, Xiaoyun
    Zeng, Lu
    Zhang, Xiaoge
    Zhang, Kun
    Li, Na
    Han, Qunying
    Liu, Zhengwen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [7] Treatment of chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists
    Abenhardt, W.
    Bosse, D.
    Boening, L.
    Bojko, P.
    Hitz, H.
    Voelki, S.
    Fromm, M.
    Mittermueller, J.
    Goeldel, N.
    Schick, H. -D.
    Dietzfelbinger, H.
    Hinke, A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (48) : 2707 - 2712
  • [8] 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders
    Mestre, Tiago A.
    Zurowski, Mateusz
    Fox, Susan H.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (04) : 411 - 421
  • [9] Hypersensitivity reactions associated with 5-hydroxytryptamine(3)-receptor antagonists: A class effect?
    Kataja, V
    deBruijn, KM
    LANCET, 1996, 347 (9001): : 584 - 585
  • [10] Current prevention and treatment of postoperative nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists: A review
    Fujii Y.
    Toyooka H.
    Journal of Anesthesia, 2001, 15 (4) : 223 - 232
12345